Additionally, a higher percentage of CD4+CTLA4+ T lymphocytes was observed in CHD-PAH patients, as compared to CTD-PAH (p < 0.001) and CTEPH (p < 0.01) patients. Here, CD4 is linked to chronic thromboembolic pulmonary hypertension.